Fluid-induced coagulopathy: Does the type of fluid make a difference?

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Marx, Gernot ^a   Schuerholz, Tobias ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; PADGEM PROTEIN;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; COLLOID; CRYSTALLOID; HEMODILUTION; HEMOSTASIS; HUMAN; INTENSIVE CARE; MOLECULAR WEIGHT; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; CHEMISTRY; FLUID THERAPY; SOLUTION AND SOLUBILITY;

BLOOD COAGULATION DISORDERS; FLUID THERAPY; HETASTARCH; HUMANS; SOLUTIONS;

EID: 77956624136     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8841     Document Type: Note

References (9)

1. Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Loesche W. HES130/0.4 impairs haemostasis and stimulates proinflammatory blood platelet function. Crit Care 2009, 13:R208. 2811952, 20028511, 10.1186/cc8223.
2. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products--different effects. Anesthesiology 2009, 111:187-202. 10.1097/ALN.0b013e3181a7ec82, 19512862.
3. Innerhofer P, Fries D, Margreiter J, Klingler A, Kühbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002, 95:858-865. table of contents, 10.1097/00000539-200210000-00012, 12351257.
4. Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001, 92:1402-1407. 10.1097/00000539-200106000-00008, 11375812.
5. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, de Gaetano G, Cerletti C. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 2006, 4:1323-1330. 10.1111/j.1538-7836.2006.01968.x, 16706978.
6. Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, Simon DI, Plow EF. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood 2008, 112:2327-2335. 2532806, 18509085, 10.1182/blood-2007-12-127183.
7. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH, Kubes P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13:463-469. 10.1038/nm1565, 17384648.
8. Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx G, Hilgers R, Forster H. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007, 98:635-644. 10.1093/bja/aem068, 17456491.
9. Boldt J, Mengistu A. Balanced hydroxyethylstarch preparations: are they all the same? In-vitro thrombelastometry and whole blood aggregometry. Eur J Anaesthesiol 2009, 26:1020-1025. 10.1097/EJA.0b013e32832f5a90, 19606044.